Cargando…

Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination

Detalles Bibliográficos
Autores principales: de Haar, Colin, Plantinga, Maud, Blokland, Nina, Spel, Lotte, Boes, Marianne, Nierkens, Stefan, Boelens, Jaap Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990352/
http://dx.doi.org/10.1186/2051-1426-1-S1-P206
_version_ 1782312266340761600
author de Haar, Colin
Plantinga, Maud
Blokland, Nina
Spel, Lotte
Boes, Marianne
Nierkens, Stefan
Boelens, Jaap Jan
author_facet de Haar, Colin
Plantinga, Maud
Blokland, Nina
Spel, Lotte
Boes, Marianne
Nierkens, Stefan
Boelens, Jaap Jan
author_sort de Haar, Colin
collection PubMed
description
format Online
Article
Text
id pubmed-3990352
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39903522014-05-01 Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination de Haar, Colin Plantinga, Maud Blokland, Nina Spel, Lotte Boes, Marianne Nierkens, Stefan Boelens, Jaap Jan J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990352/ http://dx.doi.org/10.1186/2051-1426-1-S1-P206 Text en Copyright © 2013 de Haar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
de Haar, Colin
Plantinga, Maud
Blokland, Nina
Spel, Lotte
Boes, Marianne
Nierkens, Stefan
Boelens, Jaap Jan
Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title_full Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title_fullStr Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title_full_unstemmed Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title_short Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination
title_sort development of a unique anti-aml immune therapy consisting of cord blood hsct and cord blood stem cell-derived dendritic cell (cb-dc) vaccination
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990352/
http://dx.doi.org/10.1186/2051-1426-1-S1-P206
work_keys_str_mv AT dehaarcolin developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT plantingamaud developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT bloklandnina developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT spellotte developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT boesmarianne developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT nierkensstefan developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination
AT boelensjaapjan developmentofauniqueantiamlimmunetherapyconsistingofcordbloodhsctandcordbloodstemcellderiveddendriticcellcbdcvaccination